CA2678555A1 - Amelioration de la reponse au stress cellulaire - Google Patents

Amelioration de la reponse au stress cellulaire Download PDF

Info

Publication number
CA2678555A1
CA2678555A1 CA002678555A CA2678555A CA2678555A1 CA 2678555 A1 CA2678555 A1 CA 2678555A1 CA 002678555 A CA002678555 A CA 002678555A CA 2678555 A CA2678555 A CA 2678555A CA 2678555 A1 CA2678555 A1 CA 2678555A1
Authority
CA
Canada
Prior art keywords
antibody
ra1c
polypeptide
compound
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002678555A
Other languages
English (en)
Inventor
William Mallet
Charles Tindell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2678555A1 publication Critical patent/CA2678555A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002678555A 2007-03-02 2008-03-03 Amelioration de la reponse au stress cellulaire Abandoned CA2678555A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89280607P 2007-03-02 2007-03-02
US60/892,806 2007-03-02
PCT/US2008/055714 WO2008109560A2 (fr) 2007-03-02 2008-03-03 Amélioration de la réponse au stress cellulaire

Publications (1)

Publication Number Publication Date
CA2678555A1 true CA2678555A1 (fr) 2008-09-12

Family

ID=39532129

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002678555A Abandoned CA2678555A1 (fr) 2007-03-02 2008-03-03 Amelioration de la reponse au stress cellulaire

Country Status (8)

Country Link
EP (1) EP2118133A2 (fr)
JP (1) JP2010521425A (fr)
CN (1) CN101790539A (fr)
AU (1) AU2008222926A1 (fr)
CA (1) CA2678555A1 (fr)
IL (1) IL200483A0 (fr)
MX (1) MX2009009197A (fr)
WO (1) WO2008109560A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011017520A1 (fr) * 2009-08-05 2011-02-10 Wake Forest University Health Sciences Compositions et procédés pour induire une apoptose dans des cellules de cancer de la prostate

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6790631B1 (en) * 1999-10-05 2004-09-14 Agensys, Inc. G protein-coupled receptor up-regulated in prostate cancer and uses thereof

Also Published As

Publication number Publication date
JP2010521425A (ja) 2010-06-24
EP2118133A2 (fr) 2009-11-18
CN101790539A (zh) 2010-07-28
WO2008109560A3 (fr) 2008-12-11
IL200483A0 (en) 2010-04-29
WO2008109560A2 (fr) 2008-09-12
AU2008222926A1 (en) 2008-09-12
MX2009009197A (es) 2009-09-04

Similar Documents

Publication Publication Date Title
EP2538981B1 (fr) Compositions et procedes de diagnostic et traitement de tumeurs
US7547768B2 (en) Anti-TAT 113 antibodies
US9580514B2 (en) Compositions and methods for the diagnosis and treatment of tumor
US20050170368A1 (en) Compositions and methods for the diagnosis and treatment of tumor
US20080102468A1 (en) Compositions and methods for treatment of non-hodgkin's lymphoma
EP2294197B1 (fr) Variant de protéine hhip1 et procédés d'utilisation associés
KR20130079384A (ko) 종양의 진단 및 치료를 위한 조성물 및 방법
JP5819308B2 (ja) マクロファージ刺激タンパク質のヘプシン活性化を調節するための方法及び組成物
EP2118133A2 (fr) Amélioration de la réponse au stress cellulaire
US20080193446A1 (en) Compositions and Methods for the Diagnosis and Treatment of Tumor
AU2006235436A2 (en) Compositions and methods for the diagnosis and treatment of tumor
MXPA06015122A (en) COMPOSITIONS AND METHODS FOR TREATMENT OF NON-HODGKINâÇS LYMPHOMA

Legal Events

Date Code Title Description
FZDE Discontinued